Optimizing derivatization conditions using an experimental design and simultaneous estimation of artemether and lumefantrine by ratio first order derivative spectrophotometric methodFootnote

Peer review under responsibility of Taibah University.

References

• WHO Factsheet on the World Malaria Report2014http://www.who.int/malaria/media/world_malaria_report_2014/en/
   Google Scholar
• World Malaria Report2014WHO Library
   Google Scholar
• The World Wide Antimalarial Network2014Journal.Pmed
   Google Scholar
• H.P.RangM.M.DaleJ.M.RitterR.J.FlowerRang and Dale’s Pharmacology6th ed.2007ElsevierChurchill Livingstone536
   Google Scholar
• Martindale: The Complete Drug Reference, London36th ed.2009 pp. 598–599, 605
   Google Scholar
• O.A.AdegokeA.O.OsoyeDerivatization of artesunate and dihydroartemisinin for colorimetric analysis using p-dimethylaminobenzaldehydeEurasian J. Anal. Chem.62011104
   Google Scholar
• C.P.BabalolaI.OluwalanaO.A.KotilaO.A.AdegokeY.T.KoladeS.J.AmehA novel derivatization ultraviolet spectrophotometric method for the determination of dihydroartemisinin using p-nitroanilineTrop. J. Pharm. Res.1312014127133
   Web of Science ®Google Scholar
• C.DebnathE.HaslingerW.LikussarA.MichelitschDetermination of the antimalaria drug artemether in pharmaceutical preparations by differential pulse polarographyJ. Pharm. Biomed. Anal.412006638643
   PubMed Web of Science ®Google Scholar
• J.L.FelhoferK.ScidaM.PenickP.A.WillisC.D.GarciaSimultaneous solid phase extraction and derivatization of aliphatic primary amines prior to separation and UV-absorbance detectionTalanta1152013688693
   PubMed Web of Science ®Google Scholar
• J.N.PawarR.T.SheteA.B.GangurdeDevelopment of amorphous dispersions of artemether with hydrophilic polymers via spray drying: physicochemical and in silico studiesAsian J. Pharm. Sci.112016385395
   Web of Science ®Google Scholar
• C.AgboC.UmeyorF.KenechukwuJ.OgbonnaS.ChimeC.LovelynO.AgubataK.OfokansiA.AttamaFormulation design, in vitro characterizations and anti-malarial investigations of artemether and lumefantrine-entrapped solid lipid microparticlesDrug Dev. Ind. Pharm.2016114
   Web of Science ®Google Scholar
• The International Pharmacopoeia2015 Available at http://apps.who.int/phint/en/p/docf/
   Google Scholar
• A.ShrivastavaP.SainiR.IssaraniNew simple and economical spectrophotometric method for estimation of artemether in pharmaceutical dosage formsAsian J. Res. Chem.120081921
   Google Scholar
• Government of India, Ministry of Health and Family Welfare6th ed.Indian Pharmacopoeia, Monograph of Artemethervol. II2010 p. 836
   Google Scholar
• British Pharmacopoeia, Version 11.0, Appendices: XII A, XII G, XVII G2007
   Google Scholar
• United States Pharmacopoeia and National Formulary (USP 31-NF26)2008US PharmacopoeiaRockville, MD683687
   Google Scholar
• Monographs for Antimalarial Drug. International Pharmacopoeia, pp. 187–196. Available from: http://whqlibdoc.who.int/publications/2003/9241545364_ part 4.pdf (assessed 19.07.07).
   Google Scholar
• USP’s SALMOUS Standards Guideline. Lumefantrine and Artemether Tablets2009The United States Pharmacopeial ConventionTwinbrook Parkway, Rockville
   Google Scholar
• Monographs for Antimalarial Drugsvol. 52006International Pharmacopoeia185
   Google Scholar
• P.Y.PawarM.P.ChavanG.K.GhanwatM.A.RaskarH.P.BhosaleValidated spectrophotometric method for quantitative determination of Artemether in pharmaceutical formulationDer Pharma Chem.332011135139
   Google Scholar
• D.S.CesarG.A.PianettiQuantitation of artemether in pharmaceutical raw material and injections by high performance liquid chromatographyBraz. J. Pharm. Sci.452009737742
   Web of Science ®Google Scholar
• K.VandercruyssenM.D.HondtV.VergoteH.JansenC.BurvenichB.D.SpiegeleerUV/MS quality analytics of paediatric artemether formulationsJ. Pharm. Anal.2013116
   Google Scholar
• L.WiesnerK.GovenderS.A.MeredithJ.NormanP.J.SmithA liquid–liquid LC/MS/MS assay for the determination of artemether and DHA in malaria patient sampleJ. Pharm. Biomed. Anal.552011373378
   PubMed Web of Science ®Google Scholar
• C.SouppartN.GauducheauN.SandrenanF.RichardDevelopment and validation of a high-performance liquid chromatography–mass spectrometry assay for the determination of artemether and its metabolite dihydroartemisinin in human plasmaJ. Chromatogr. B7742002195203
   PubMed Web of Science ®Google Scholar
• L.HuangA.L.JayewardeneF.MarzanP.S.LizakF.T.AweekaDevelopment and validation of a high-performance liquid chromatography/tandem mass spectrometry method for the determination of artemether and its active metabolite dihydroartemisinin in human plasmaJ. Pharm. Biomed. Anal.502009959965
   PubMed Web of Science ®Google Scholar
• A.ShrivastavaR.IssaraniStability indicating high-performance liquid chromatography method for the estimation of artemether in capsule dosage formsJ. Young Pharm.220107984
   PubMedGoogle Scholar
• N.G.TayadeM.S.NagarsenkerValidated HPTLC method of analysis for artemether and its formulationsJ. Pharm. Biomed. Anal.432007839844
   PubMed Web of Science ®Google Scholar
• S.SharmaM.C.SharmaSimultaneous UV spectrophotometric method for the estimation of lumefantrine in pharmaceutical dosage formsWorld J. Chem.620117579
   Google Scholar
• R.ArunA.S.AntonDevelopment of analytical method for lumefantrine by UV spectrophotometryInt. J. Res. Pharm. Sci.12010321324
   Google Scholar
• R.PrasannaD.SaravananJ.PadmavathyMethod development and validation for the determination of lumefantrine in sold dosage form by RP-HPLCInt. J. Pharm. Res. Dev.820108490
   Google Scholar
• I.F.KhalilU.AbildrupL.H.AlifrangisD.MaigaM.AlifrangisL.HoegbergI.C.BygbjergMeasurement of lumefantrine and its metabolite in plasma by high performance liquid chromatography with ultraviolet detectionJ. Pharm. Biomed. Anal.12011168172
   Web of Science ®Google Scholar
• N.S.KoturS.SivasamyS.SrinivasanAnalytical method development and validation for estimation of lumefantrine in pharmaceutical dosage forms by HPLCJ. Pharm. Sci. Res.42012162167
   Google Scholar
• R.ArunA.A.SmithSimultaneous HPLC-UV method for the estimation of artemether and lumefantrine in tablet dosage formJ. Pharm. Biomed. Anal.482011951954
   Google Scholar
• J.SunilM.S.NathM.U.SambaHPLC method development and validation for simultaneous estimation of artemether and lumefantrine in pharmaceutical dosage formsInt. J. Pharm. Sci.4201047
   Google Scholar
• C.CostaF.HenriqueA.NogueiraSimultaneous determination of artemether and lumefantrine in fixed dose combination tablets by HPLC with UV detectionJ. Pharm. Biomed. Anal.482008951954
   PubMed Web of Science ®Google Scholar
• B.SridharR.K.HanumanthaT.V.SrinivasM.V.SeshuK.MadhuriJ.V.SeshagiriA validated reverse phase HPLC method for the simultaneous estimation of artemether and lumefantrine in pharmaceutical dosage formsInt. J. Adv. Pharm. Sci.12010
   Google Scholar
• T.M.KalyankarR.B.KakdeReversed-phase liquid chromatographic method for simultaneous determination of artemether and lumefantrine in pharmaceutical preparationInt. J. ChemTech. Res.3201117221727
   Google Scholar
• D.ParasharA.KumarR.M.RayasaSimultaneous estimation of artemether and lumefantrine in pharmaceutical dosage forms using derivative spectrophotometryAsian J. Res. Chem.62013226
   Google Scholar
• T.M.KalyankarM.S.AttarS.D.DeosarkarDevelopment UV–visible spectrophotometric method for simultaneous estimation of artemether and lumefantrineAnal. Chem. Ind. J.12201383
   Google Scholar
• P.K.SajniR.M.SinghS.C.MathurG.N.SinghC.L.JainR.K.KharA.A.HafeezA simple and sensitive HPTLC method for quantitative analysis of artemether and lumefantrine in tabletsJ. Planar Chromatogr.232010119122
   Web of Science ®Google Scholar
• G.A.LewisD.M.RogerP.LuuPharmaceutical Experimental Design1999Marcel Dekker, Inc.New York2
   Google Scholar
• A.SetiaS.KansalN.GoyaliDevelopment and optimization of enteric coated mucoadhesive microspheres of duloxetine hydrochloride using 32 full factorial designInt. J. Pharm. Investig.32013141150
   PubMedGoogle Scholar
• J.AntonyFull Factorial Designs, Design of Experiments for Engineers and Scientists2014Elsevier Ltd
   Google Scholar
• N.BarkaM.AbdennouriA.BoussaoudA.GaladiM.BaalalaM.BensitelA.Sahibed-DineK.NohairM.F.SadiqFull factorial experimental design applied to oxalic acid photocatalytic degradation in TiO2 aqueous suspensionArab. J. Chem.72014752757
   Web of Science ®Google Scholar
• R.A.CazarOptimization of a UV–visible spectrophotometer response using a fractional factorial designAvances322011A1A4
   Google Scholar
• L.KumarR.M.SreenivasaR.S.ManaguliK.G.PaiFull factorial design for optimization, development and validation of HPLC method to determine valsartan in nanoparticlesSaudi Pharm. J.232015549555
   PubMed Web of Science ®Google Scholar
• J.M.LeitaoD.E.SilvaFactorial analysis optimization of a Diltiazem kinetic spectrophotometric quantification methodAnal. Chim. Acta6092008112
   PubMed Web of Science ®Google Scholar
• H.PatelH.PatelM.GohelS.TiwariDissolution rate improvement of telmisartan through modified MCC pellets using 32 full factorial designSaudi Pharm J.2015
   Web of Science ®Google Scholar
• F.S.RojasC.B.OjedaA.JesusR.SanchezM.E.BoschUse of experimental design for calibration and validation of ascorbic acid and citric acid mixturesJ. Mex. Chem. Soc.522008229234
   Web of Science ®Google Scholar
• U.TezcanF.AtesN.ErginelO.OzcanE.OduncuAdsorption of disperse orange 30 dye onto activated carbon derived from Holm Oak (Quercus Ilex) acorns: A 3k factorial design and analysisJ. Environ. Manag.15520158996
   PubMed Web of Science ®Google Scholar
• D.R.VananiS.D.DesaiK.G.PatelP.A.ShahApplication of ratio derivative spectrophotometry for simultaneous Determination of Mometasone furoate and salicylic acid in semisolid dosage formInt. J. Anal. Bioanal. Chem.320136771
   Google Scholar
• A.R.RotelP.D.BarilRatio spectra derivative and zero-crossing difference spectrophotometric determination of olmesartan medoxomil and hydrochlorothiazide in combined pharmaceutical dosage formAAPS PharmSciTech102009
   Web of Science ®Google Scholar
• Validation of analytical procedures: text and methodologyInternational Conference on Harmonization, ICH Q2 (R1) ICH Secretariat, Geneva2005
   Google Scholar
• J.H.ZarBiostatical Analysis5th ed.2010Pearson Education Inc.New Jersey
   Google Scholar
• T.SivakumarR.ManavalanK.ValliappanDevelopment and validation of a reversed-phase HPLC method for simultaneous determination of domperidone and pantoprazole in pharmaceutical dosage formsActa Chromatogr.182007130142
   Web of Science ®Google Scholar
• T.B.SolankiP.A.ShahK.G.PatelCentral composite design for validation of HPTLC method for simultaneous estimation of olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide in tabletsIndian J. Pharm. Sci.762014179187
   PubMed Web of Science ®Google Scholar
• G.MustafaA.AhujaS.BabootaJ.AliBox-Behnken supported validation of stability-indicating high performance thin-layer chromatography (HPTLC) method: an application in degradation kinetic profiling of ropiniroleSaudi Pharm. J.21201393102
   PubMed Web of Science ®Google Scholar
• V.Sree JanardhananR.ManavalanK.ValliappanChemometric technique for the optimization of chromatographic system: simultaneous HPLC determination of rosuvastatin, telmisartan, ezetimibe and atorvastatin used in combined cardiovascular therapyArab. J. Chem.2012110
   Google Scholar